A human COVID-19 vaccine trial by the biotech company Moderna has shown promising early results, it reported on Monday, producing antibodies in all 45 human participants. CNBC reports: “Each participant received a 25, 100 or 250 microgram dose, with 15 people in each dose group. Participants received two doses of the potential vaccine via intramuscular injection … Continue reading Moderna Vaccine Trial Shows Promise; COVID-19 Antibodies Produced in All 45 Participants; Trump Appointee’s Stock Value Surges $3.4 Million